Followers

Saturday, September 5, 2020

COVID-19 origins: genome analysis recommends two viruses may have united. Is it reality or not ?

 

  • Scientists have been trying to understand the origin of COVID-19 and the virus that causes it: SARS-CoV-2.
  • Originally, scientists believed the virus may have developed in bats, and later pangolins.
  • However, genomic comparisons suggest that the SARS-Cov-2 virus is the result of a recombination between two different viruses, meaning the exact origin of the virus is still unclear.

In the space of a few weeks, we have all learned a lot about COVID-19 and the virus that causes it: SARS-CoV-2. But there have also been a lot of rumors. And while the number of scientific articles on this virus is increasing, there are still many grey areas as to its origins.

In which animal species did it occur? A bat, a pangolin or another wild species? Where does it come from? From a cave or a forest in the Chinese province of Hubei, or elsewhere?

In December 2019, 27 of the first 41 people hospitalized (66%) passed through a market located in the heart of Wuhan city in Hubei province. But, according to a study conducted at Wuhan Hospital, the very first human case identified did not frequent this market. Instead, a molecular dating estimate based on the SARS-CoV-2 genomic sequences indicates an origin in November. This raises questions about the link between this COVID-19 epidemic and wildlife.

Genomic data

The SARS-CoV-2 genome was rapidly sequenced by Chinese researchers. It is an RNA  molecule of about 30,000 bases containing 15 genes, including the S gene which codes for a protein located on the surface of the viral envelope (for comparison, our genome is in the form of a double helix of DNA about 3 billion bases in size and contains about 30,000 genes).

Comparative genomic analyses have shown that SARS-CoV-2 belongs to the group of Betacoronaviruses and that it is very close to SARS-CoV, responsible for an epidemic of acute pneumonia which appeared in November 2002 in the Chinese province of Guangdong and then spread to 29 countries in 2003. A total of 8,098 cases were recorded, including 774 deaths. It is known that bats of the genus Rhinolophus (potentially several cave species) were the reservoir of this virus and that a small carnivore, the palm civet (Paguma larvata), may have served as an intermediate host between bats and the first human cases.

Since then, many Betacoronaviruses have been discovered, mainly in bats, but also in humans. For example, RaTG13, isolated from a bat of the species Rhinolophus affinis collected in China’s Yunan Province, has recently been described as very similar to SARS-CoV-2, with genome sequences identical to 96%. These results indicate that bats, and in particular species of the genus Rhinolophus, constitute the reservoir of the SARS-CoV and SARS-CoV-2 viruses.

Bat, Rhinolophus affinis. Alexandre Hassanin, Author provided Coronavirus china virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia  pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
AddBats (Rhinolophus affinis) were originally thought to be the source of virus.
Image: Alexandre Hassanin 

But how do you define a reservoir? A reservoir is one or several animal species that are not or not very sensitive to the virus, which will naturally host one or several viruses. The absence of symptoms of the disease is explained by the effectiveness of their immune system, which allows them to fight against too much viral proliferation.

Recombination mechanism

On February 7, 2020, we learned that a virus even closer to SARS-CoV-2 had been discovered in pangolin. With 99% of genomic concordance reported, this suggested a more likely reservoir than bats. However, a recent study under review shows that the genome of the coronavirus isolated from the Malaysian pangolin (Manis javanica) is less similar to SARS-Cov-2, with only 90% of genomic concordance. This would indicate that the virus isolated in the pangolin is not responsible for the COVID-19 epidemic currently raging.

However, the coronavirus isolated from pangolin is similar at 99% in a specific region of the S protein, which corresponds to the 74 amino acids involved in the ACE (Angiotensin Converting Enzyme 2) receptor binding domain, the one that allows the virus to enter human cells to infect them. By contrast, the virus RaTG13 isolated from bat R. affinis is highly divergent in this specific region (only 77 % of similarity). This means that the coronavirus isolated from pangolin is capable of entering human cells whereas the one isolated from bat R. affinis is not.

In addition, these genomic comparisons suggest that the SARS-Cov-2 virus is the result of a recombination between two different viruses, one close to RaTG13 and the other closer to the pangolin virus. In other words, it is a chimera between two pre-existing viruses.

This recombination mechanism had already been described in coronaviruses, in particular to explain the origin of SARS-CoV. It is important to know that recombination results in a new virus potentially capable of infecting a new host species. For recombination to occur, the two divergent viruses must have infected the same organism simultaneously.

Two questions remain unanswered: in which organism did this recombination occur? (a bat, a pangolin or another species?) And above all, under what conditions did this recombination take place?

 

 

Sunday, February 2, 2020

Coronavirus: A Death Whole

By Debasray Saha

The new coronavirus: What we do — and don’t — know


Approx 300 peoples are died by corona virus. This virus enters in chinese peoples by in taking sea food. They were mostly prefer sea foods instead of other non vegs. This virus enters in human body and just damaging the respiratory organs or it blocks the respiratory pathway that's why the death rate will increase. 
             A 44-year-old man in the Philippines has died of the corona virus, health officials said on Sunday, making him the first known death outside China. The man, a resident of Wuhan, China, the epicenter of the virus, died on Saturday after developing what officials called “severe pneumonia.”
             Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sir Lanka, Finland, Sweden.
A gloved hand holding a blood sample vial marked Coronavirus positive             Actually this virus were introduced in 1960s and that time it was discovered in chickens that is infectious bronchitis virus and two viruses from the nasal cavities of human patients with the common cold which named as human corona virus 229E and human corona virus OC43. After that many viruses of same family were introduced in different years just like :SARS-CoV in 2003, HCoV NL63 in 2004, HKU1 in 2005, MERS-CoV in 2012, and 2019-nCoV in 2019. 
             The last one which introduced in 2019 which named as nCoV ha complex structure and our respected scientists are facing problems for making drugs for the nCoV. 
             As we know first time corona virus is introduced in chickens and humans so much as possible try to avoid the beef, chicken, egg, etc and also avoid the edibles which are preserved more then 48 hrs. Because these are very good sources of this virus.  

The bottom line

2019-nCoV-CDC-23312 without background.png
Render of 2019 nCoV virion
Given the current spread of this virus and the pace and complexity of international travel, the number of cases and deaths will likely to continue to climb. We should not panic, even though we are dealing with a serious and novel pathogen. Public health teams are assembling. Lessons learned from other serious viruses, such as SARS and MERS, will help. As more information becomes available, public health organizations like the Centers for Disease Control (CDC) in the US and the World Health Organization (WHO) will be sharing key information and strategies worldwide.

Friday, October 18, 2019

Glenmark Pharma gets USFDA approval for prostate cancer treatment drug .The approved product is a generic version of Zytiga tablets, 250 mg, of Janssen Biotech

Drug firm Glenmark Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Abiraterone Acetate tablets used to treat prostate cancer.

The approved product is a generic version of Zytiga tablets, 250 mg, of Janssen Biotech. "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg," the company said in a regulatory filing. 

Citing IQVIA deals information for the year time frame finishing August 2019, Glenmark said the Zytiga tablets, 250 mg market accomplished yearly offers of roughly USD 794.1 million.

Glenmark's present portfolio comprises of 162 items approved for dissemination in the US commercial center and 46 ANDA's pending endorsement with the USFDA.

Portions of Glenmark Pharma were exchanging 0.15 percent higher at Rs 286.00 each on the BSE.

 Feel free to send me comments about this article.

COVID-19 origins: genome analysis recommends two viruses may have united. Is it reality or not ?

  Scientists have been trying to understand the origin of COVID-19 and the virus that causes it: SARS-CoV-2. Originally, scien...